MarketCap
Facebook
X
TelegramAnnual report 2022
added 03-30-2023
Apollo Endosurgery Operating Income 2011-2026 | APEN
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Apollo Endosurgery
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -31.4 M | -19.2 M | -15.8 M | -23.5 M | -40.1 M | -22.4 M | -20.8 M | -16.7 M | -17.8 M | -7.59 M | -5.56 M | -3.71 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -3.71 M | -40.1 M | -18.7 M |
Quarterly Operating Income Apollo Endosurgery
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -6.29 M | - | -7.25 M | - | -4.5 M | -5.24 M | -3.75 M | - | -1.57 M | -4.3 M | -6.68 M | - | -6.86 M | -7.2 M | -2.54 M | - | -8.1 M | -7.51 M | -7.63 M | - | -4.28 M | -5.47 M | -6.81 M | - | -3.72 M | -6.26 M | -3.02 M | - | -2.23 M | -3.27 M | -3.02 M | - | -3.57 M | -4.33 M | -3.1 M | - | -1.78 M | -1.93 M | -1.48 M | - | -1.35 M | -1.08 M | -1.23 M | - | -701 K | -632 K | 96 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 96 K | -8.1 M | -3.96 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Delcath Systems
DCTH
|
660 K | $ 8.98 | -1.32 % | $ 322 M |  USA |
 |
FONAR Corporation
FONR
|
5.31 M | $ 18.41 | 0.38 % | $ 121 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Inogen
INGN
|
-30.2 M | $ 6.32 | -2.02 % | $ 168 M | USA |
 |
IRadimed Corporation
IRMD
|
26.1 M | $ 100.97 | 1.78 % | $ 1.28 B | USA |
 |
BioSig Technologies
BSGM
|
-12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
LivaNova PLC
LIVN
|
199 M | $ 62.4 | -1.33 % | $ 3.4 B |  Britain |
 |
Medtronic PLC
MDT
|
5.96 B | $ 86.58 | -0.68 % | $ 111 B | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
Orthofix Medical
OFIX
|
-81.4 M | $ 11.72 | -1.26 % | $ 464 M |  Curacao |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
IRIDEX Corporation
IRIX
|
-10 M | $ 1.35 | - | $ 21.8 M | USA |
 |
Penumbra
PEN
|
189 M | $ 334.17 | -0.41 % | $ 13 B | USA |
 |
LENSAR
LNSR
|
-10.7 M | $ 5.56 | -8.4 % | $ 64 M | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
Insulet Corporation
PODD
|
474 M | $ 225.5 | -0.7 % | $ 15.9 B | USA |
 |
Profound Medical Corp.
PROF
|
-30.3 M | $ 5.15 | -4.63 % | $ 180 M |  Canada |
 |
Quanterix Corporation
QTRX
|
-126 M | $ 3.82 | -3.05 % | $ 163 M | USA |
 |
AxoGen
AXGN
|
-7.85 M | $ 32.61 | 2.71 % | $ 1.5 B | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 36.56 | -0.19 % | $ 1.13 B | USA |
 |
Electromed
ELMD
|
9.66 M | $ 24.7 | 0.86 % | $ 209 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M | Canada |
 |
Sintx Technologies
SINT
|
-10.7 M | $ 2.57 | 0.78 % | $ 7.13 M | USA |
 |
Sensus Healthcare
SRTS
|
-10.3 M | $ 3.96 | -3.65 % | $ 64.7 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-16.8 M | $ 0.7 | 3.3 % | $ 38.1 M | USA |
 |
Aethlon Medical
AEMD
|
-9.34 M | $ 2.16 | -6.09 % | $ 3.37 M | USA |
 |
Stryker Corporation
SYK
|
4.89 B | $ 328.51 | -1.23 % | $ 126 B | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
AdaptHealth Corp.
AHCO
|
90.9 M | $ 11.48 | 10.7 % | $ 1.55 B | USA |
 |
Tandem Diabetes Care
TNDM
|
8.29 M | $ 24.51 | -2.31 % | $ 1.67 B | USA |
 |
Myomo
MYO
|
-14.4 M | $ 0.7 | -1.83 % | $ 29.3 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-56.7 M | $ 2.4 | -1.64 % | $ 141 M |  Israel |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 3.91 | 4.83 % | $ 146 M |  France |
 |
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 15.91 | -3.4 % | $ 373 M | USA |
 |
Outset Medical
OM
|
-66.7 M | $ 3.53 | -2.35 % | $ 53.7 K | USA |